Richard Mead

Professor of Translational Neuroscience, University of Sheffield

Professor Richard Mead is Professor of Translational Neuroscience at the Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield. His research focuses on developing new treatments for motor neuron disease (MND/ALS) and other neurodegenerative disorders by translating discoveries in disease biology into therapeutic strategies.

Professor Mead’s work spans target identification, preclinical drug discovery, and the development of translational biomarkers to support early clinical studies. His research has contributed to the advancement of neuroprotective approaches, including therapies targeting oxidative stress pathways such as NRF2, as well as gene and cell-based treatment strategies. He works closely with academic, clinical, and industry partners to accelerate the progression of promising therapies towards clinical testing.